Research Priorities in Atrial Fibrillation Screening

Author:

Benjamin Emelia J.12ORCID,Go Alan S.345ORCID,Desvigne-Nickens Patrice6ORCID,Anderson Christopher D.7ORCID,Casadei Barbara8ORCID,Chen Lin Y.9ORCID,Crijns Harry J.G.M.10ORCID,Freedman Ben11ORCID,Hills Mellanie True12ORCID,Healey Jeff S.13ORCID,Kamel Hooman14ORCID,Kim Dong-Yun15ORCID,Link Mark S.16ORCID,Lopes Renato D.17ORCID,Lubitz Steven A.18ORCID,McManus David D.19ORCID,Noseworthy Peter A.20ORCID,Perez Marco V.1ORCID,Piccini Jonathan P.17ORCID,Schnabel Renate B.2122ORCID,Singer Daniel E.23ORCID,Tieleman Robert G.2425ORCID,Turakhia Mintu P.2627ORCID,Van Gelder Isabelle C.24ORCID,Cooper Lawton S.6ORCID,Al-Khatib Sana M.17ORCID

Affiliation:

1. Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, MA (E.J.B.).

2. Department of Epidemiology, Boston University School of Public Health, MA (E.J.B.).

3. Division of Research, Kaiser Permanente Northern California, Oakland (A.S.G.).

4. Departments of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco (A.S.G.).

5. Departments of Medicine, Health Research, and Policy (A.S.G.), Stanford University, CA.

6. Division of Cardiovascular Sciences (P.D.-N., L.S.C.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

7. Department of Neurology, Center for Genomic Medicine, and McCance Center for Brain Health, Massachusetts General Hospital, Boston (C.D.A.).

8. Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK (B.C.).

9. Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis (L.Y.C.).

10. Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands (H.J.G.M.C.).

11. Heart Research Institute, Charles Perkins Centre, and Concord Hospital Department of Cardiology, Concord Clinical School, University of Sydney, Australia (B.F.).

12. StopAfib.org, American Foundation for Women’s Health, Decatur, TX (M.T.H.).

13. Population Health Research Institute, McMaster University, Hamilton, ON, Canada (J.S.H.).

14. Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY (H.K.).

15. Office of Biostatistics Research (D.-Y.K.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

16. Department of Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX (M.S.L.).

17. Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.D.L., J.P.P., S.M.A.-K.).

18. Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston (S.A.L.).

19. Department of Medicine, Division of Cardiology, University of Massachusetts Medical School, Worcester (D.D.M.).

20. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (P.A.N.).

21. Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany (R.B.S.).

22. DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Luebeck, Germany (R.B.S.).

23. Division of General Internal Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, (D.E.S.).

24. Department of Cardiology, University of Groningen, University Medical Center Groningen, the Netherlands (I.C.V.G., R.G.T.).

25. Department of Cardiology, Martini Hospital, Groningen, the Netherlands (R.G.T.).

26. Center for Digital Health (M.P.T.), Stanford University, CA.

27. Veterans Affairs Palo Alto Health Care System, CA (M.P.T.).

Abstract

Clinically recognized atrial fibrillation (AF) is associated with higher risk of complications, including ischemic stroke, cognitive decline, heart failure, myocardial infarction, and death. It is increasingly recognized that AF frequently is undetected until complications such as stroke or heart failure occur. Hence, the public and clinicians have an intense interest in detecting AF earlier. However, the most appropriate strategies to detect undiagnosed AF (sometimes referred to as subclinical AF) and the prognostic and therapeutic implications of AF detected by screening are uncertain. Our report summarizes the National Heart, Lung, and Blood Institute’s virtual workshop focused on identifying key research priorities related to AF screening. Global experts reviewed major knowledge gaps and identified critical research priorities in the following areas: (1) role of opportunistic screening; (2) AF as a risk factor, risk marker, or both; (3) relationship between AF burden detected with long-term monitoring and outcomes/treatments; (4) designs of potential randomized trials of systematic AF screening with clinically relevant outcomes; and (5) role of AF screening after ischemic stroke. Our report aims to inform and catalyze AF screening research that will advance innovative, resource-efficient, and clinically relevant studies in diverse populations to improve the diagnosis, management, and prognosis of patients with undiagnosed AF.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3